Pharmafile Logo
Pharmafocus logo
Advanced Search

Novartis

Showing 15 posts of 823 posts found.

Lilly image

Lilly and Novartis face legal challenges

June 25, 2015
Medical Communications, Sales and Marketing Gleevec, Glivec, Novartis, cymbalta, imatinib, lilly, zyprexa

Judges in California have ruled that Lilly should face claims it failed to fully disclose the extent of post-withdrawal side …

News

Pfizer acquires meningitis vaccines from GSK

June 23, 2015
Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis

Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …

News

Amgen and Novartis tussle over biosimilar injunction

June 4, 2015
Sales and Marketing Amgen, FDA, Neupogen, Novartis

Novartis has begun its court battle with Amgen over its biosimilar of cancer drug Neupogen, which Amgen is trying to …

News
novartis_window

NICE green-light for Novartis skin drug

May 29, 2015
Sales and Marketing Cosentyx, IL-17, NICE, Novartis, Secukinumab

NICE has released positive draft guidance for three treatments, including the first in a new generation of psoriasis drugs. Novartis’ …

News
Novartis image

Novartis reveals ASCO plans

May 27, 2015
Sales and Marketing ASCO, GSK, Novartis

Novartis’ first ASCO conference since buying GlaxoSmithKline’s oncology business will be showcasing drugs from the acquisition. The two firms swapped …

News
Bayer image

Survey reveals pharma’s most reputable companies

May 14, 2015
Medical Communications, Sales and Marketing Novartis, nayer, reputation

Bayer has held on to the top spot in a global survey of how much the general public trusts and …

News
sandoz image

Novartis invests further into Poland

May 11, 2015
Manufacturing and Production, Sales and Marketing Novartis, Poland, Sandoz, manufacturing, packaging

Sandoz the generics division of Novartis has opened a large packaging centre in Stryków in Poland. Valued at 171 million …

News

US Court blocks Novartis biosimilar Neupogen

May 8, 2015
Sales and Marketing Neupogen, Novartis, Zarxio, biosimilar, filagrastim, filgrastim-sndz

Novartis have been temporarily prevented from marketing its biosimilar version of Amgen’s drug Neupogen in the US. Earlier this year …

News
GSk image

Boardroom shuffles at GSK and Roche

May 8, 2015
Medical Communications, Sales and Marketing GSK, Novartis, Roche, ViiV, changes, leadership

GlaxoSmithKline and Roche have announced the latest changes to its leadership teams as the companies regroup for the year ahead. …

News
GSK image

Generics continue to erode GSK sales

May 6, 2015
Sales and Marketing GSK, HIV, Novartis, Q1, ViiV, Witty, hampton, respiratory

GlaxoSmithKline’s pharma sales continued to slide in the first quarter of 2015, but ViiV healthcare and the portfolios acquired from …

News

Novartis and Abbott start year with strong Q1 sales

April 23, 2015
Sales and Marketing Abbott, Amgen, Cosentyx, GSK, Neupogen, Novartis, Secukinumab, Zarxio, biosimilar, filgrastim, financials

Novartis and Abbott have both posted strong first-quarter results and made bullish predictions about their financial performance in 2015. Novartis …

News
Boehringer image

Boehringer Ingelheim and Bayer ‘taking the lead’ in social media

April 22, 2015
Medical Communications, Sales and Marketing Bayer, Boehringer Ingelheim, J&J and Merck, Novartis, Ogilvy Healthworld

Pharma may be finally embracing social media as a vehicle for engaging with doctors and patients, after posting more than …

News

Novartis MS drug scores positive late-stage trial result

April 21, 2015
Research and Development, Sales and Marketing MS, Novartis, fingolimod, gilenya, multiple sclerosis

People with some of the most common forms of multiple sclerosis (MS) who are treated with Gilenya are less likely …

News
GSK image

GSK sees further US job losses following Novartis deal

April 17, 2015
Research and Development, Sales and Marketing GSK, Jobs, Novartis, cuts, merger, pittsburgh, restructuring

Hundreds more jobs are at risk within GlaxoSmithKline as the fallout from the company’s asset-swapping deal with Novartis continues. Staff …

News
Novartis image

Novartis to highlight Gilenya data at neurology congress

April 13, 2015
Sales and Marketing American Academy of Neurology, Novartis, fingolimod, gilenya

Novartis will be highlighting data for its multiple sclerosis drug Gilenya at this year’s American Academy of Neurology (AAN) annual …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025